Stephanie Yuen Owyang, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Helicobacter pylori | 8 | 2020 | 382 | 1.120 |
Why?
|
| Helicobacter Infections | 6 | 2020 | 392 | 1.020 |
Why?
|
| Transforming Growth Factor beta | 3 | 2020 | 1963 | 0.760 |
Why?
|
| Immune Tolerance | 3 | 2020 | 2307 | 0.640 |
Why?
|
| Dendritic Cells | 6 | 2020 | 2726 | 0.510 |
Why?
|
| DNA, Bacterial | 3 | 2012 | 1470 | 0.410 |
Why?
|
| T-Lymphocytes, Regulatory | 3 | 2020 | 3092 | 0.320 |
Why?
|
| Colonic Neoplasms | 1 | 2017 | 2527 | 0.250 |
Why?
|
| Inflammatory Bowel Diseases | 4 | 2018 | 2421 | 0.240 |
Why?
|
| Autoimmune Diseases | 2 | 2018 | 2244 | 0.230 |
Why?
|
| Peptic Ulcer | 2 | 2018 | 216 | 0.230 |
Why?
|
| B-Lymphocytes | 1 | 2017 | 4744 | 0.230 |
Why?
|
| Gastric Mucosa | 2 | 2020 | 603 | 0.210 |
Why?
|
| T-Lymphocytes | 1 | 2017 | 10203 | 0.170 |
Why?
|
| Adenocarcinoma | 1 | 2017 | 6341 | 0.170 |
Why?
|
| Cell Growth Processes | 1 | 2017 | 382 | 0.140 |
Why?
|
| Cytokines | 4 | 2017 | 7386 | 0.130 |
Why?
|
| Neoplasm Transplantation | 1 | 2017 | 2010 | 0.110 |
Why?
|
| Colitis | 2 | 2012 | 1234 | 0.110 |
Why?
|
| Butyrates | 1 | 2012 | 169 | 0.100 |
Why?
|
| Genetic Engineering | 1 | 2017 | 930 | 0.100 |
Why?
|
| Immunity | 1 | 2017 | 996 | 0.090 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2013 | 344 | 0.090 |
Why?
|
| Mice, Nude | 1 | 2017 | 3606 | 0.090 |
Why?
|
| Interleukin-23 | 1 | 2012 | 201 | 0.090 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2017 | 1048 | 0.090 |
Why?
|
| Anti-Bacterial Agents | 2 | 2018 | 7407 | 0.080 |
Why?
|
| Mice, Inbred BALB C | 1 | 2017 | 6200 | 0.080 |
Why?
|
| Mice, Inbred C57BL | 5 | 2020 | 22128 | 0.080 |
Why?
|
| Immune Evasion | 1 | 2009 | 364 | 0.070 |
Why?
|
| Mice | 6 | 2020 | 81330 | 0.060 |
Why?
|
| Tumor Microenvironment | 1 | 2017 | 3875 | 0.060 |
Why?
|
| Intestinal Mucosa | 2 | 2012 | 3031 | 0.060 |
Why?
|
| Animals | 7 | 2020 | 168089 | 0.060 |
Why?
|
| Interleukin-17 | 1 | 2009 | 913 | 0.050 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2009 | 1803 | 0.050 |
Why?
|
| Cell Line, Tumor | 1 | 2017 | 16954 | 0.050 |
Why?
|
| Polymyositis | 1 | 2018 | 75 | 0.040 |
Why?
|
| Bismuth | 1 | 2017 | 29 | 0.040 |
Why?
|
| Cephalosporins | 1 | 2018 | 198 | 0.040 |
Why?
|
| Pemphigus | 1 | 2018 | 107 | 0.040 |
Why?
|
| Taiwan | 1 | 2018 | 522 | 0.040 |
Why?
|
| Sjogren's Syndrome | 1 | 2018 | 238 | 0.030 |
Why?
|
| Models, Biological | 1 | 2012 | 9458 | 0.030 |
Why?
|
| Dermatomyositis | 1 | 2018 | 258 | 0.030 |
Why?
|
| Disease Models, Animal | 2 | 2012 | 18222 | 0.030 |
Why?
|
| Scleroderma, Systemic | 1 | 2018 | 345 | 0.030 |
Why?
|
| Vasculitis | 1 | 2018 | 522 | 0.030 |
Why?
|
| Proton Pump Inhibitors | 1 | 2017 | 534 | 0.030 |
Why?
|
| Urinary Tract Infections | 1 | 2018 | 801 | 0.030 |
Why?
|
| Gastritis | 1 | 2013 | 199 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2017 | 2643 | 0.020 |
Why?
|
| Salvage Therapy | 1 | 2017 | 1264 | 0.020 |
Why?
|
| Dextran Sulfate | 1 | 2011 | 258 | 0.020 |
Why?
|
| Species Specificity | 1 | 2013 | 2406 | 0.020 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2013 | 1435 | 0.020 |
Why?
|
| Stomach | 1 | 2013 | 697 | 0.020 |
Why?
|
| Interleukin-12 | 1 | 2011 | 578 | 0.020 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2009 | 307 | 0.020 |
Why?
|
| Th1 Cells | 1 | 2013 | 1042 | 0.020 |
Why?
|
| Microscopy, Fluorescence, Multiphoton | 1 | 2009 | 267 | 0.020 |
Why?
|
| Immunity, Mucosal | 1 | 2011 | 485 | 0.020 |
Why?
|
| Mortality | 1 | 2018 | 2896 | 0.020 |
Why?
|
| Adoptive Transfer | 1 | 2009 | 823 | 0.020 |
Why?
|
| Interferon Type I | 1 | 2011 | 557 | 0.020 |
Why?
|
| Th17 Cells | 1 | 2013 | 794 | 0.020 |
Why?
|
| Colitis, Ulcerative | 1 | 2018 | 1920 | 0.020 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2018 | 2157 | 0.020 |
Why?
|
| Crohn Disease | 1 | 2018 | 2278 | 0.020 |
Why?
|
| Cells, Cultured | 2 | 2012 | 18927 | 0.020 |
Why?
|
| Inflammation Mediators | 1 | 2013 | 1885 | 0.010 |
Why?
|
| Interleukin-10 | 1 | 2009 | 1176 | 0.010 |
Why?
|
| Antigens, Bacterial | 1 | 2009 | 1140 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2018 | 12474 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2011 | 2916 | 0.010 |
Why?
|
| Microscopy, Confocal | 1 | 2009 | 1967 | 0.010 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2018 | 3753 | 0.010 |
Why?
|
| Humans | 5 | 2018 | 761222 | 0.010 |
Why?
|
| Forkhead Transcription Factors | 1 | 2009 | 1613 | 0.010 |
Why?
|
| Female | 6 | 2018 | 392552 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2018 | 22174 | 0.010 |
Why?
|
| Incidence | 1 | 2018 | 21366 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 2009 | 5478 | 0.010 |
Why?
|
| Escherichia coli | 1 | 2011 | 4201 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2013 | 14392 | 0.010 |
Why?
|
| Middle Aged | 3 | 2018 | 220858 | 0.010 |
Why?
|
| Bacterial Proteins | 1 | 2009 | 3836 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2011 | 9319 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2009 | 12747 | 0.010 |
Why?
|
| Male | 3 | 2018 | 360703 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2009 | 10423 | 0.010 |
Why?
|
| Adult | 2 | 2018 | 221120 | 0.010 |
Why?
|
| Aged | 2 | 2018 | 169292 | 0.010 |
Why?
|
| United States | 1 | 2017 | 72341 | 0.010 |
Why?
|
| Time Factors | 1 | 2009 | 39957 | 0.000 |
Why?
|